Related Experiment Videos
[From gene disease; alpha1-antitrypsine deficiency]
1Leids Universitair Medisch Centrum, afd. Longziekten, Postbus 9600, 2300 RC Leiden. p.s.hiemstra@lumc.nl
Nederlands Tijdschrift Voor Geneeskunde
|May 7, 2003
Summary
Alpha-1-antitrypsin (alpha 1-AT) deficiency is a genetic disorder causing lung and liver disease. The Z mutant form of alpha 1-AT leads to its accumulation, causing emphysema due to reduced lung protection.
Area of Science:
- Genetics and Molecular Biology
- Pulmonology
- Hepatology
Context:
- Alpha-1-antitrypsin (alpha 1-AT) deficiency is an autosomal, recessive hereditary disorder.
- It is linked to the development of pulmonary emphysema and liver disease.
- The Z mutant is the most common genetic variant associated with alpha 1-AT deficiency.
Purpose:
- To explain the genetic basis and molecular mechanisms of Alpha-1-antitrypsin (alpha 1-AT) deficiency.
- To elucidate the link between alpha 1-AT deficiency and the pathogenesis of pulmonary emphysema and liver disease.
Summary:
- Alpha-1-antitrypsin (alpha 1-AT) deficiency arises from autosomal, recessive inheritance.
- The Z mutant form of alpha 1-AT causes polymer formation, leading to hepatic accumulation and reduced secretion.
- Pulmonary emphysema is attributed to inadequate protection of lung tissue from neutrophil elastase activity due to low local alpha 1-AT levels.
Impact:
- Provides insight into the molecular pathology of a common genetic disorder affecting the lungs and liver.
- Highlights the critical role of alpha 1-AT in preventing protease-induced tissue damage.
- Informs potential therapeutic strategies targeting alpha 1-AT deficiency and its associated diseases.